Ownership and insider activity for RadNet, Inc. (RDNT): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures.
Price
| Price | $70.57 |
| Market Cap | $5.5B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-18 | SWARTZ DAVID L | S-Sale | 2,699 | $145K |
| 2026-06-16 | Wesdorp Cornelis | S-Sale | 4,750 | $276K |
| 2026-06-16 | Berger Howard G | G-Gift | 90 | |
| 2026-06-15 | Forthuber Stephen M | S-Sale | 24,214 | $1.4M |
| 2026-06-15 | Forthuber Stephen M | S-Sale | 19,853 | $1.2M |
| 2026-06-02 | SWARTZ DAVID L | A-Award | 2,946 | |
| 2026-06-02 | SPURLOCK GREGORY E. | A-Award | 2,946 | |
| 2026-06-02 | Jacobs Laura Pastre | A-Award | 2,946 | |
| 2026-06-02 | Levitt Lawrence L | A-Award | 2,946 | |
| 2026-05-05 | Berger Howard G | M-Exempt | 25,992 | $484K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20.6M | $51.3M | $10.4M | $40.2M | $102.0M | $134.6M | $127.8M | $342.6M | $740.0M | $767.2M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $166.6M | $157.9M | $149.5M | $156.0M | $135.4M | $140.4M | $185.3M | $189.0M | $227.7M | $212.9M |
| Inventory | $2.2M | 0 | $2.5M | $2.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $217.9M | $235.4M | $208.7M | $241.8M | $270.4M | $324.3M | $367.2M | $579.3M | $1.02B | $1.03B |
| Property, Plant & Equipment | $247.7M | $244.3M | $345.7M | $812.2M | $883.0M | $1.07B | $1.17B | $1.20B | $1.33B | $3.00B |
| Goodwill | $239.6M | $256.8M | $418.1M | $441.0M | $472.9M | $513.8M | $677.7M | $679.5M | $710.7M | $907.7M |
| Intangible Assets | $42.7M | $40.4M | $40.6M | $43.0M | $52.4M | $56.6M | $106.2M | $90.6M | $81.4M | $148.5M |
| Total Assets | $849.5M | $869.0M | $1.11B | $1.65B | $1.79B | $2.06B | $2.43B | $2.69B | $3.29B | $3.76B |
| Accounts Payable | $41.0M | $28.5M | $68.0M | $64.3M | $70.1M | $86.5M | $102.7M | $122.9M | $96.5M | $153.2M |
| Short-term Debt | $26.6M | $34.1M | $39.3M | $104.2M | $39.8M | $11.2M | $12.4M | $18.0M | $24.7M | $25.4M |
| Total Current Liabilities | $155.3M | $191.6M | $239.5M | $326.0M | $398.1M | $374.8M | $466.7M | $437.5M | $479.7M | $586.8M |
| Long-term Debt | $609.4M | $572.4M | $626.5M | $652.7M | $612.9M | $743.5M | $839.3M | $812.1M | $991.6M | $1.06B |
| Total Liabilities | $797.4M | $799.1M | $909.1M | $1.41B | $1.53B | $1.71B | $1.94B | $1.88B | $2.15B | $2.40B |
| Retained Earnings | -$150.5M | -$150.2M | -$117.9M | -$103.2M | -$118.0M | -$93.3M | -$82.6M | -$79.6M | -$76.8M | -$95.4M |
| Total Equity | $48.5M | $61.6M | $127.2M | $151.7M | $165.7M | $228.9M | $333.0M | $630.7M | $902.3M | $1.09B |
| Total Debt | $638.7M | $613.0M | $672.3M | $1.25B | $1.18B | $1.40B | $1.51B | $1.49B | $1.73B | $1.86B |
| Net Debt | $618.1M | $561.7M | $661.9M | $1.21B | $1.08B | $1.26B | $1.39B | $1.15B | $988.8M | $1.09B |
| Working Capital | $62.6M | $43.7M | -$30.8M | -$84.2M | -$127.7M | -$50.5M | -$99.5M | $141.8M | $539.5M | $445.4M |
Financial Health
| Debt / Equity | 1.99 |
| Current Ratio | 1.48 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 2.07 |
Profitability
| Return on Equity | -1.95% |
| Return on Invested Capital | 1.38% |
| Return on Assets | -0.50% |
| Gross Margin | 9.70% |
| Operating Margin | 4.00% |
| Net Margin | -0.93% |
Related companies: BLCO · BRKR · BTSG · CHE · IRTC · KRYS · MMSI
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of RDNT: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks